An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Amicus Therapeutics (Nasdaq: FOLD) will participate in investor conferences in November. The UBS Biopharma Conference will be held on November 9th at 1:00 p.m. E.T. in Miami, FL. The Stifel 2023 Healthcare Conference will be held on November 15th at 8:00 a.m. E.T. in New York, NY. The presentations can be accessed via the Amicus Therapeutics corporate website.
Positive
None.
Negative
None.
PRINCETON, N.J., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November.
UBS Biopharma Conference in Miami, FL on Thursday, November 9, 2023, at 1:00 p.m. E.T.
Stifel 2023 Healthcare Conference in New York, NY on Wednesday, November 15, 2023, at 8:00 a.m. E.T.
About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on Twitter and LinkedIn.
Media: Amicus Therapeutics Diana Moore Head of Global Corporate Communications dmoore@amicusrx.com (609) 662-5079
FOLD–G
FAQ
When and where will Amicus Therapeutics participate in investor conferences in November?
Amicus Therapeutics will participate in the UBS Biopharma Conference on November 9th in Miami, FL, and the Stifel 2023 Healthcare Conference on November 15th in New York, NY.
How can I access the presentations?
The presentations can be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations.
amicus therapeutics is a global, patient-centric biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. we have a unique set of platform technologies and medicines in development for patients living with the lysosomal storage disorders fabry disease and pompe disease and we are committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for these and other rare diseases. the needs of patients in the rare disease community are at the center of our inventive science, our commercial organization, and our clinical programs. our goal throughout all levels of the organization is to make a meaningful difference in the lives of these patients and their caregivers. several opportunities are available to join our team as we build a leading global biotechnology company focused on rare metabolic diseases. our amicus footprint spans 27 countries including our g
